5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Future Directions in Multiple Myeloma: Selinexor Approval, Venetoclax, Belantamab Mafodotin, BCMA:CD3 Bispecifics & CAR T
Comments 0
Login to view comments.
Click here to Login